Interferon regulatory factors: At the crossroads of immunity, metabolism, and disease

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1852, Issue 2, 2015, Pages 365-378

  Zhao, Guang Nian ^a,b   Jiang, Ding Sheng ^a,b   Li, Hongliang ^a,b  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

Disease; Immunity; IRFs; Metabolism; Stress sensor

Indexed keywords

DNA; INTERFERON REGULATORY FACTOR; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1;

ARTICLE; AUTOPHAGY; B LYMPHOCYTE; BONE MARROW CELL; CARDIOVASCULAR DISEASE; CELL SURFACE; IMMUNE RESPONSE; IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; INNATE IMMUNITY; METABOLIC DISORDER; METABOLISM; NATURAL KILLER CELL; NEUROLOGIC DISEASE; NONHUMAN; PROTEIN QUALITY; QUALITY CONTROL; SENSOR; SIGNAL TRANSDUCTION; STRESS; T LYMPHOCYTE; ANIMAL; BIOLOGICAL MODEL; DISEASES; HUMAN;

MAMMALIA;

ANIMALS; DISEASE; HUMANS; IMMUNITY; IMMUNITY, INNATE; INTERFERON REGULATORY FACTORS; METABOLISM; MODELS, BIOLOGICAL;

EID: 84919795881     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2014.04.030     Document Type: Article

References (138)

1. Tamura T., Yanai H., Savitsky D., Taniguchi T. The IRF family transcription factors in immunity and oncogenesis. Annu. Rev. Immunol. 2008, 26:535-584.
2. Honda K., Taniguchi T. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat. Rev. Immunol. 2006, 6:644-658.
3. Panne D., Maniatis T., Harrison S.C. An atomic model of the interferon-beta enhanceosome. Cell 2007, 129:1111-1123.
4. Chen W., Royer W.E. Structural insights into interferon regulatory factor activation. Cell. Signal. 2010, 22:883-887.
5. Savitsky D., Tamura T., Yanai H., Taniguchi T. Regulation of immunity and oncogenesis by the IRF transcription factor family. Cancer Immunol. Immunother. 2010, 59:489-510.
6. Yanai H., Negishi H., Taniguchi T. The IRF family of transcription factors: Inception, impact and implications in oncogenesis. Oncoimmunology 2012, 1:1376-1386.
7. Eguchi J., Yan Q.W., Schones D.E., Kamal M., Hsu C.H., Zhang M.Q., Crawford G.E., Rosen E.D. Interferon regulatory factors are transcriptional regulators of adipogenesis. Cell Metab. 2008, 7:86-94.
8. Eguchi J., Wang X., Yu S., Kershaw E.E., Chiu P.C., Dushay J., Estall J.L., Klein U., Maratos-Flier E., Rosen E.D. Transcriptional control of adipose lipid handling by IRF4. Cell Metab. 2011, 13:249-259.
9. Wang X.A., Zhang R., Zhang S., Deng S., Jiang D., Zhong J., Yang L., Wang T., Hong S., Guo S., She Z.G., Zhang X.D., Li H. Interferon regulatory factor 7 deficiency prevents diet-induced obesity and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 2013, 305:E485-E495.
10. Wang X.A., Zhang R., Jiang D., Deng W., Zhang S., Deng S., Zhong J., Wang T., Zhu L.H., Yang L., Hong S., Guo S., Chen K., Zhang X.F., She Z., Chen Y., Yang Q., Zhang X.D., Li H. Interferon regulatory factor 9 protects against hepatic insulin resistance and steatosis in male mice. Hepatology 2013, 58:603-616.
11. Wang X.A., Zhang R., She Z.G., Zhang X.F., Jiang D.S., Wang T., Gao L., Deng W., Zhang S.M., Zhu L.H., Guo S., Chen K., Zhang X.D., Liu D.P., Li H. Interferon regulatory factor 3 constrains IKKbeta/NF-kappaB signaling to alleviate hepatic steatosis and insulin resistance. Hepatology 2014, 59:870-885.
12. Petrasek J., Iracheta-Vellve A., Csak T., Satishchandran A., Kodys K., Kurt-Jones E.A., Fitzgerald K.A., Szabo G. STING-IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:16544-16549.
13. Doring Y., Soehnlein O., Drechsler M., Shagdarsuren E., Chaudhari S.M., Meiler S., Hartwig H., Hristov M., Koenen R.R., Hieronymus T., Zenke M., Weber C., Zernecke A. Hematopoietic interferon regulatory factor 8-deficiency accelerates atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. 2012, 32:1613-1623.
14. Lu J., Bian Z.Y., Zhang R., Zhang Y., Liu C., Yan L., Zhang S.M., Jiang D.S., Wei X., Zhu X.H., Chen M., Wang A.B., Chen Y., Yang Q., Liu P.P., Li H. Interferon regulatory factor 3 is a negative regulator of pathological cardiac hypertrophy. Basic Res. Cardiol. 2013, 108:326.
15. Jiang D.S., Bian Z.Y., Zhang Y., Zhang S.M., Liu Y., Zhang R., Chen Y., Yang Q., Zhang X.D., Fan G.C., Li H. Role of interferon regulatory factor 4 in the regulation of pathological cardiac hypertrophy. Hypertension 2013, 61:1193-1202.
16. Jiang D.S., Liu Y., Zhou H., Zhang Y., Zhang X.D., Zhang X.F., Chen K., Gao L., Peng J., Gong H., Chen Y., Yang Q., Liu P.P., Fan G.C., Zou Y., Li H. Interferon Regulatory Factor 7 Functions as a Novel Negative Regulator of Pathological Cardiac Hypertrophy. Hypertension 2014, 63:713-722.
17. Jiang D.S., Luo Y.X., Zhang R., Zhang X.D., Chen H.Z., Zhang Y., Chen K., Zhang S.M., Fan G.C., Liu P.P., Liu D.P., Li H. Interferon Regulatory Factor 9 Protects Against Cardiac Hypertrophy by Targeting Myocardin. Hypertension 2014, 63:119-127.
18. Jiang D.S., Li L., Huang L., Gong J., Xia H., Liu X., Wan N., Wei X., Zhu X., Chen Y., Chen X., Zhang X.D., Li H. Interferon Regulatory Factor 1 Is Required for Cardiac Remodeling in Response to Pressure Overload. Hypertension 2014, 10.1161/HYPERTENSIONAHA.114.03229.
19. Zhang S.M., Gao L., Zhang X.F., Zhang R., Zhu L.H., Wang P.X., Tian S., Yang D., Chen K., Huang L., Zhang X.D., Li H. Interferon Regulatory Factor 8 Modulates Phenotypic Switching of Smooth Muscle Cells through Regulating the Activity of Myocardin. Mol. Cell. Biol. 2014, 34:400-414.
20. Zhang S.M., Zhu L.H., Li Z.Z., Wang P.X., Chen H.Z., Guan H.J., Jiang D.S., Chen K., Zhang X.F., Tian S., Yang D., Zhang X.D., Li H. Interferon regulatory factor 3 protects against adverse neo-intima formation. Cardiovasc. Res. 2014, 10.1093/cvr/cvu052.
21. Jiang D.S., Wei X., Zhang X.F., Liu Y., Zhang Y., Chen K., Gao L., Zhou H., Zhu X.H., Liu P.P., Bond Lau W., Ma X., Zou Y., Zhang X.D., Fan G.C., Li H. IRF8 suppresses pathological cardiac remodelling by inhibiting calcineurin signalling. Nat. Commun. 2014, 5:3303.
22. Xiang M., Wang L., Guo S., Lu Y.Y., Lei H., Jiang D.S., Zhang Y., Liu Y., Zhou Y., Zhang X.D., Li H. Interferon Regulatory Factor 8 Protects Against Cerebral Ischaemic-Reperfusion Injury. J. Neurochem. 2014, 10.1111/jnc.12682.
23. Yoshida Y., Yoshimi R., Yoshii H., Kim D., Dey A., Xiong H., Munasinghe J., Yazawa I., O'Donovan M.J., Maximova O.A., Sharma S., Zhu J., Wang H., Morse H.C., Ozato K. The Transcription Factor IRF8 Activates Integrin-Mediated TGF-beta Signaling and Promotes Neuroinflammation. Immunity 2014, 40:187-198.
24. Guo S., Li Z.Z., Jiang D.S., Lu Y.Y., Liu Y., Gao L., Zhang S.M., Lei H., Zhu L.H., Zhang X.D., Liu D.P., Li H. IRF4 is a novel mediator for neuronal survival in ischaemic stroke. Cell Death Differ. 2014, 21:888-903.
25. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140:805-820.
26. Ikushima H., Negishi H., Taniguchi T. The IRF Family Transcription Factors at the Interface of Innate and Adaptive Immune Responses. Cold Spring Harb. Symp. Quant. Biol. 2013, 10.1101/sqb.2013.78.020321.
27. Lee M.S., Kim Y.J. Signaling pathways downstream of pattern-recognition receptors and their cross talk. Annu. Rev. Biochem. 2007, 76:447-480.
28. Kawai T., Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011, 34:637-650.
29. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 2010, 11:373-384.
30. Honda K., Yanai H., Negishi H., Asagiri M., Sato M., Mizutani T., Shimada N., Ohba Y., Takaoka A., Yoshida N., Taniguchi T. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 2005, 434:772-777.
31. Balkhi M.Y., Fitzgerald K.A., Pitha P.M. Functional regulation of MyD88-activated interferon regulatory factor 5 by K63-linked polyubiquitination. Mol. Cell. Biol. 2008, 28:7296-7308.
32. Chen W., Lam S.S., Srinath H., Jiang Z., Correia J.J., Schiffer C.A., Fitzgerald K.A., Lin K., Royer W.E. Insights into interferon regulatory factor activation from the crystal structure of dimeric IRF5. Nat. Struct. Mol. Biol. 2008, 15:1213-1220.
33. Negishi H., Fujita Y., Yanai H., Sakaguchi S., Ouyang X., Shinohara M., Takayanagi H., Ohba Y., Taniguchi T., Honda K. Evidence for licensing of IFN-gamma-induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction program. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:15136-15141.
34. Negishi H., Ohba Y., Yanai H., Takaoka A., Honma K., Yui K., Matsuyama T., Taniguchi T., Honda K. Negative regulation of Toll-like-receptor signaling by IRF-4. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:15989-15994.
35. Geijtenbeek T.B., Gringhuis S.I. Signalling through C-type lectin receptors: shaping immune responses. Nat. Rev. Immunol. 2009, 9:465-479.
36. Sancho D., Reis e Sousa C. Signaling by myeloid C-type lectin receptors in immunity and homeostasis. Annu. Rev. Immunol. 2012, 30:491-529.
37. del Fresno C., Soulat D., Roth S., Blazek K., Udalova I., Sancho D., Ruland J., Ardavin C. Interferon-beta production via Dectin-1-Syk-IRF5 signaling in dendritic cells is crucial for immunity to C. albicans. Immunity 2013, 38:1176-1186.
38. Kawai T., Takahashi K., Sato S., Coban C., Kumar H., Kato H., Ishii K.J., Takeuchi O., Akira S. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 2005, 6:981-988.
39. Lazear H.M., Lancaster A., Wilkins C., Suthar M.S., Huang A., Vick S.C., Clepper L., Thackray L., Brassil M.M., Virgin H.W., Nikolich-Zugich J., Moses A.V., Gale M., Fruh K., Diamond M.S. IRF-3, IRF-5, and IRF-7 coordinately regulate the type I IFN response in myeloid dendritic cells downstream of MAVS signaling. PLoS Pathog. 2013, 9:e1003118.
40. Holm C.K., Paludan S.R., Fitzgerald K.A. DNA recognition in immunity and disease. Curr. Opin. Immunol. 2013, 25:13-18.
41. Paludan S.R., Bowie A.G. Immune sensing of DNA. Immunity 2013, 38:870-880.
42. Ishikawa H., Barber G.N. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 2008, 455:674-678.
43. Tanaka Y., Chen Z.J. STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway. Sci. Signal. 2012, 5:ra20.
44. Burdette D.L., Monroe K.M., Sotelo-Troha K., Iwig J.S., Eckert B., Hyodo M., Hayakawa Y., Vance R.E. STING is a direct innate immune sensor of cyclic di-GMP. Nature 2011, 478:515-518.
45. Gao D., Wu J., Wu Y.T., Du F., Aroh C., Yan N., Sun L., Chen Z.J. Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses. Science 2013, 341:903-906.
46. Sun L., Wu J., Du F., Chen X., Chen Z.J. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 2013, 339:786-791.
47. Wu J., Sun L., Chen X., Du F., Shi H., Chen C., Chen Z.J. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 2013, 339:826-830.
48. Unterholzner L., Keating S.E., Baran M., Horan K.A., Jensen S.B., Sharma S., Sirois C.M., Jin T., Latz E., Xiao T.S., Fitzgerald K.A., Paludan S.R., Bowie A.G. IFI16 is an innate immune sensor for intracellular DNA. Nat. Immunol. 2010, 11:997-1004.
49. Jakobsen M.R., Bak R.O., Andersen A., Berg R.K., Jensen S.B., Tengchuan J., Laustsen A., Hansen K., Ostergaard L., Fitzgerald K.A., Xiao T.S., Mikkelsen J.G., Mogensen T.H., Paludan S.R. IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:E4571-E4580.
50. Orzalli M.H., DeLuca N.A., Knipe D.M. Nuclear IFI16 induction of IRF-3 signaling during herpesviral infection and degradation of IFI16 by the viral ICP0 protein. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:E3008-E3017.
51. Parvatiyar K., Zhang Z., Teles R.M., Ouyang S., Jiang Y., Iyer S.S., Zaver S.A., Schenk M., Zeng S., Zhong W., Liu Z.J., Modlin R.L., Liu Y.J., Cheng G. The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune response. Nat. Immunol. 2012, 13:1155-1161.
52. Zhang Z., Yuan B., Bao M., Lu N., Kim T., Liu Y.J. The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells. Nat. Immunol. 2011, 12:959-965.
53. Yang P., An H., Liu X., Wen M., Zheng Y., Rui Y., Cao X. The cytosolic nucleic acid sensor LRRFIP1 mediates the production of type I interferon via a beta-catenin-dependent pathway. Nat. Immunol. 2010, 11:487-494.
54. Kondo T., Kobayashi J., Saitoh T., Maruyama K., Ishii K.J., Barber G.N., Komatsu K., Akira S., Kawai T. DNA damage sensor MRE11 recognizes cytosolic double-stranded DNA and induces type I interferon by regulating STING trafficking. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:2969-2974.
55. Wen H., Miao E.A., Ting J.P. Mechanisms of NOD-like receptor-associated inflammasome activation. Immunity 2013, 39:432-441.
56. Sabbah A., Chang T.H., Harnack R., Frohlich V., Tominaga K., Dube P.H., Xiang Y., Bose S. Activation of innate immune antiviral responses by Nod2. Nat. Immunol. 2009, 10:1073-1080.
57. Chang Foreman H.C., Van Scoy S., Cheng T.F., Reich N.C. Activation of interferon regulatory factor 5 by site specific phosphorylation. PLoS ONE 2012, 7:e33098.
58. Negishi H., Yanai H., Nakajima A., Koshiba R., Atarashi K., Matsuda A., Matsuki K., Miki S., Doi T., Aderem A., Nishio J., Smale S.T., Honda K., Taniguchi T. Cross-interference of RLR and TLR signaling pathways modulates antibacterial T cell responses. Nat. Immunol. 2012, 13:659-666.
59. Belz G.T., Nutt S.L. Transcriptional programming of the dendritic cell network. Nat. Rev. Immunol. 2012, 12:101-113.
60. Bajana S., Roach K., Turner S., Paul J., Kovats S. IRF4 promotes cutaneous dendritic cell migration to lymph nodes during homeostasis and inflammation. J. Immunol. 2012, 189:3368-3377.
61. Schlitzer A., McGovern N., Teo P., Zelante T., Atarashi K., Low D., Ho A.W., See P., Shin A., Wasan P.S., Hoeffel G., Malleret B., Heiseke A., Chew S., Jardine L., Purvis H.A., Hilkens C.M., Tam J., Poidinger M., Stanley E.R., Krug A.B., Renia L., Sivasankar B., Ng L.G., Collin M., Ricciardi-Castagnoli P., Honda K., Haniffa M., Ginhoux F. IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses. Immunity 2013, 38:970-983.
62. Persson E.K., Uronen-Hansson H., Semmrich M., Rivollier A., Hagerbrand K., Marsal J., Gudjonsson S., Hakansson U., Reizis B., Kotarsky K., Agace W.W. IRF4 transcription-factor-dependent CD103(+)CD11b(+) dendritic cells drive mucosal T helper 17 cell differentiation. Immunity 2013, 38:958-969.
63. Kumamoto Y., Linehan M., Weinstein J.S., Laidlaw B.J., Craft J.E., Iwasaki A. CD301b(+) dermal dendritic cells drive T helper 2 cell-mediated immunity. Immunity 2013, 39:733-743.
64. Gao Y., Nish S.A., Jiang R., Hou L., Licona-Limon P., Weinstein J.S., Zhao H., Medzhitov R. Control of T Helper 2 Responses by Transcription Factor IRF4-Dependent Dendritic Cells. Immunity 2013, 39:722-732.
65. Esashi E., Wang Y.H., Perng O., Qin X.F., Liu Y.J., Watowich S.S. The signal transducer STAT5 inhibits plasmacytoid dendritic cell development by suppressing transcription factor IRF8. Immunity 2008, 28:509-520.
66. Tailor P., Tamura T., Morse H.C., Ozato K. The BXH2 mutation in IRF8 differentially impairs dendritic cell subset development in the mouse. Blood 2008, 111:1942-1945.
67. Becker A.M., Michael D.G., Satpathy A.T., Sciammas R., Singh H., Bhattacharya D. IRF-8 extinguishes neutrophil production and promotes dendritic cell lineage commitment in both myeloid and lymphoid mouse progenitors. Blood 2012, 119:2003-2012.
68. Hambleton S., Salem S., Bustamante J., Bigley V., Boisson-Dupuis S., Azevedo J., Fortin A., Haniffa M., Ceron-Gutierrez L., Bacon C.M., Menon G., Trouillet C., McDonald D., Carey P., Ginhoux F., Alsina L., Zumwalt T.J., Kong X.F., Kumararatne D., Butler K., Hubeau M., Feinberg J., Al-Muhsen S., Cant A., Abel L., Chaussabel D., Doffinger R., Talesnik E., Grumach A., Duarte A., Abarca K., Moraes-Vasconcelos D., Burk D., Berghuis A., Geissmann F., Collin M., Casanova J.L., Gros P. IRF8 mutations and human dendritic-cell immunodeficiency. N. Engl. J. Med. 2011, 365:127-138.
69. Hildner K., Edelson B.T., Purtha W.E., Diamond M., Matsushita H., Kohyama M., Calderon B., Schraml B.U., Unanue E.R., Diamond M.S., Schreiber R.D., Murphy T.L., Murphy K.M. Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science 2008, 322:1097-1100.
70. Tussiwand R., Lee W.L., Murphy T.L., Mashayekhi M., Wumesh K.C., Albring J.C., Satpathy A.T., Rotondo J.A., Edelson B.T., Kretzer N.M., Wu X., Weiss L.A., Glasmacher E., Li P., Liao W., Behnke M., Lam S.S., Aurthur C.T., Leonard W.J., Singh H., Stallings C.L., Sibley L.D., Schreiber R.D., Murphy K.M. Compensatory dendritic cell development mediated by BATF-IRF interactions. Nature 2012, 490:502-507.
71. Murphy T.L., Tussiwand R., Murphy K.M. Specificity through cooperation: BATF-IRF interactions control immune-regulatory networks. Nat. Rev. Immunol. 2013, 13:499-509.
72. Gabriele L., Fragale A., Borghi P., Sestili P., Stellacci E., Venditti M., Schiavoni G., Sanchez M., Belardelli F., Battistini A. IRF-1 deficiency skews the differentiation of dendritic cells toward plasmacytoid and tolerogenic features. J. Leukoc. Biol. 2006, 80:1500-1511.
73. Honda K., Mizutani T., Taniguchi T. Negative regulation of IFN-alpha/beta signaling by IFN regulatory factor 2 for homeostatic development of dendritic cells. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:2416-2421.
74. Ichikawa E., Hida S., Omatsu Y., Shimoyama S., Takahara K., Miyagawa S., Inaba K., Taki S. Defective development of splenic and epidermal CD4+ dendritic cells in mice deficient for IFN regulatory factor-2. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:3909-3914.
75. Yamamoto M., Kato T., Hotta C., Nishiyama A., Kurotaki D., Yoshinari M., Takami M., Ichino M., Nakazawa M., Matsuyama T., Kamijo R., Kitagawa S., Ozato K., Tamura T. Shared and distinct functions of the transcription factors IRF4 and IRF8 in myeloid cell development. PLoS ONE 2011, 6:e25812.
76. Molawi K., Sieweke M.H. Transcriptional control of macrophage identity, self-renewal, and function. Adv. Immunol. 2013, 120:269-300.
77. Tamura T., Thotakura P., Tanaka T.S., Ko M.S., Ozato K. Identification of target genes and a unique cis element regulated by IRF-8 in developing macrophages. Blood 2005, 106:1938-1947.
78. Chang T.H., Xu S., Tailor P., Kanno T., Ozato K. The small ubiquitin-like modifier-deconjugating enzyme sentrin-specific peptidase 1 switches IFN regulatory factor 8 from a repressor to an activator during macrophage activation. J. Immunol. 2012, 189:3548-3556.
79. Kurotaki D., Osato N., Nishiyama A., Yamamoto M., Ban T., Sato H., Nakabayashi J., Umehara M., Miyake N., Matsumoto N., Nakazawa M., Ozato K., Tamura T. Essential role of the IRF8-KLF4 transcription factor cascade in murine monocyte differentiation. Blood 2013, 121:1839-1849.
80. Marquis J.F., Kapoustina O., Langlais D., Ruddy R., Dufour C.R., Kim B.H., MacMicking J.D., Giguere V., Gros P. Interferon regulatory factor 8 regulates pathways for antigen presentation in myeloid cells and during tuberculosis. PLoS Genet. 2011, 7:e1002097.
81. Krausgruber T., Blazek K., Smallie T., Alzabin S., Lockstone H., Sahgal N., Hussell T., Feldmann M., Udalova I.A. IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat. Immunol. 2011, 12:231-238.
82. Satoh T., Takeuchi O., Vandenbon A., Yasuda K., Tanaka Y., Kumagai Y., Miyake T., Matsushita K., Okazaki T., Saitoh T., Honma K., Matsuyama T., Yui K., Tsujimura T., Standley D.M., Nakanishi K., Nakai K., Akira S. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat. Immunol. 2010, 11:936-944.
83. Milanovic M., Terszowski G., Struck D., Liesenfeld O., Carstanjen D. IFN consensus sequence binding protein (Icsbp) is critical for eosinophil development. J. Immunol. 2008, 181:5045-5053.
84. Hida S., Tadachi M., Saito T., Taki S. Negative control of basophil expansion by IRF-2 critical for the regulation of Th1/Th2 balance. Blood 2005, 106:2011-2017.
85. Testa U., Stellacci E., Pelosi E., Sestili P., Venditti M., Orsatti R., Fragale A., Petrucci E., Pasquini L., Belardelli F., Gabriele L., Battistini A. Impaired myelopoiesis in mice devoid of interferon regulatory factor 1. Leukemia 2004, 18:1864-1871.
86. Duncan G.S., Mittrucker H.W., Kagi D., Matsuyama T., Mak T.W. The transcription factor interferon regulatory factor-1 is essential for natural killer cell function in vivo. J. Exp. Med. 1996, 184:2043-2048.
87. Lohoff M., Duncan G.S., Ferrick D., Mittrucker H.W., Bischof S., Prechtl S., Rollinghoff M., Schmitt E., Pahl A., Mak T.W. Deficiency in the transcription factor interferon regulatory factor (IRF)-2 leads to severely compromised development of natural killer and T helper type 1 cells. J. Exp. Med. 2000, 192:325-336.
88. Ohteki T., Yoshida H., Matsuyama T., Duncan G.S., Mak T.W., Ohashi P.S. The transcription factor interferon regulatory factor 1 (IRF-1) is important during the maturation of natural killer 1.1+ T cell receptor-alpha/beta+ (NK1+ T) cells, natural killer cells, and intestinal intraepithelial T cells. J. Exp. Med. 1998, 187:967-972.
89. Ogasawara K., Hida S., Azimi N., Tagaya Y., Sato T., Yokochi-Fukuda T., Waldmann T.A., Taniguchi T., Taki S. Requirement for IRF-1 in the microenvironment supporting development of natural killer cells. Nature 1998, 391:700-703.
90. Taki S., Nakajima S., Ichikawa E., Saito T., Hida S. IFN regulatory factor-2 deficiency revealed a novel checkpoint critical for the generation of peripheral NK cells. J. Immunol. 2005, 174:6005-6012.
91. Wang H., Lee C.H., Qi C., Tailor P., Feng J., Abbasi S., Atsumi T., Morse H.C. IRF8 regulates B-cell lineage specification, commitment, and differentiation. Blood 2008, 112:4028-4038.
92. Lu R., Medina K.L., Lancki D.W., Singh H. IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development. Genes Dev. 2003, 17:1703-1708.
93. Ma S., Turetsky A., Trinh L., Lu R. IFN regulatory factor 4 and 8 promote Ig light chain kappa locus activation in pre-B cell development. J. Immunol. 2006, 177:7898-7904.
94. Johnson K., Hashimshony T., Sawai C.M., Pongubala J.M., Skok J.A., Aifantis I., Singh H. Regulation of immunoglobulin light-chain recombination by the transcription factor IRF-4 and the attenuation of interleukin-7 signaling. Immunity 2008, 28:335-345.
95. Cattoretti G., Shaknovich R., Smith P.M., Jack H.M., Murty V.V., Alobeid B. Stages of germinal center transit are defined by B cell transcription factor coexpression and relative abundance. J. Immunol. 2006, 177:6930-6939.
96. Sciammas R., Shaffer A.L., Schatz J.H., Zhao H., Staudt L.M., Singh H. Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation. Immunity 2006, 25:225-236.
97. Lee C.H., Melchers M., Wang H., Torrey T.A., Slota R., Qi C.F., Kim J.Y., Lugar P., Kong H.J., Farrington L., van der Zouwen B., Zhou J.X., Lougaris V., Lipsky P.E., Grammer A.C., Morse H.C. Regulation of the germinal center gene program by interferon (IFN) regulatory factor 8/IFN consensus sequence-binding protein. J. Exp. Med. 2006, 203:63-72.
98. Zhou J.X., Lee C.H., Qi C.F., Wang H., Naghashfar Z., Abbasi S., Morse H.C. IFN regulatory factor 8 regulates MDM2 in germinal center B cells. J. Immunol. 2009, 183:3188-3194.
99. Feng J., Wang H., Shin D.M., Masiuk M., Qi C.F., Morse H.C. IFN regulatory factor 8 restricts the size of the marginal zone and follicular B cell pools. J. Immunol. 2011, 186:1458-1466.
100. Ochiai K., Maienschein-Cline M., Simonetti G., Chen J., Rosenthal R., Brink R., Chong A.S., Klein U., Dinner A.R., Singh H., Sciammas R. Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4. Immunity 2013, 38:918-929.
101. Saito M., Gao J., Basso K., Kitagawa Y., Smith P.M., Bhagat G., Pernis A., Pasqualucci L., Dalla-Favera R. A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma. Cancer Cell 2007, 12:280-292.
102. Sciammas R., Li Y., Warmflash A., Song Y., Dinner A.R., Singh H. An incoherent regulatory network architecture that orchestrates B cell diversification in response to antigen signaling. Mol. Syst. Biol. 2011, 7:495.
103. Simonetti G., Carette A., Silva K., Wang H., De Silva N.S., Heise N., Siebel C.W., Shlomchik M.J., Klein U. IRF4 controls the positioning of mature B cells in the lymphoid microenvironments by regulating NOTCH2 expression and activity. J. Exp. Med. 2013, 210:2887-2902.
104. Yao S., Buzo B.F., Pham D., Jiang L., Taparowsky E.J., Kaplan M.H., Sun J. Interferon regulatory factor 4 sustains CD8(+) T cell expansion and effector differentiation. Immunity 2013, 39:833-845.
105. Raczkowski F., Ritter J., Heesch K., Schumacher V., Guralnik A., Hocker L., Raifer H., Klein M., Bopp T., Harb H., Kesper D.A., Pfefferle P.I., Grusdat M., Lang P.A., Mittrucker H.W., Huber M. The transcription factor Interferon Regulatory Factor 4 is required for the generation of protective effector CD8+ T cells. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:15019-15024.
106. Man K., Miasari M., Shi W., Xin A., Henstridge D.C., Preston S., Pellegrini M., Belz G.T., Smyth G.K., Febbraio M.A., Nutt S.L., Kallies A. The transcription factor IRF4 is essential for TCR affinity-mediated metabolic programming and clonal expansion of T cells. Nat. Immunol. 2013, 14:1155-1165.
107. Huber M., Heink S., Pagenstecher A., Reinhard K., Ritter J., Visekruna A., Guralnik A., Bollig N., Jeltsch K., Heinemann C., Wittmann E., Buch T., Prazeres da Costa O., Brustle A., Brenner D., Mak T.W., Mittrucker H.W., Tackenberg B., Kamradt T., Lohoff M. IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis. J. Clin. Invest. 2013, 123:247-260.
108. Kano S., Sato K., Morishita Y., Vollstedt S., Kim S., Bishop K., Honda K., Kubo M., Taniguchi T. The contribution of transcription factor IRF1 to the interferon-gamma-interleukin 12 signaling axis and TH1 versus TH-17 differentiation of CD4+ T cells. Nat. Immunol. 2008, 9:34-41.
109. Honma K., Kimura D., Tominaga N., Miyakoda M., Matsuyama T., Yui K. Interferon regulatory factor 4 differentially regulates the production of Th2 cytokines in naive vs. effector/memory CD4+ T cells. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:15890-15895.
110. Brustle A., Heink S., Huber M., Rosenplanter C., Stadelmann C., Yu P., Arpaia E., Mak T.W., Kamradt T., Lohoff M. The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4. Nat. Immunol. 2007, 8:958-966.
111. Biswas P.S., Gupta S., Chang E., Song L., Stirzaker R.A., Liao J.K., Bhagat G., Pernis A.B. Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice. J. Clin. Invest. 2010, 120:3280-3295.
112. Valdez P.A., Vithayathil P.J., Janelsins B.M., Shaffer A.L., Williamson P.R., Datta S.K. Prostaglandin E2 suppresses antifungal immunity by inhibiting interferon regulatory factor 4 function and interleukin-17 expression in T cells. Immunity 2012, 36:668-679.
113. Glasmacher E., Agrawal S., Chang A.B., Murphy T.L., Zeng W., Vander Lugt B., Khan A.A., Ciofani M., Spooner C.J., Rutz S., Hackney J., Nurieva R., Escalante C.R., Ouyang W., Littman D.R., Murphy K.M., Singh H. A genomic regulatory element that directs assembly and function of immune-specific AP-1-IRF complexes. Science 2012, 338:975-980.
114. Ciofani M., Madar A., Galan C., Sellars M., Mace K., Pauli F., Agarwal A., Huang W., Parkurst C.N., Muratet M., Newberry K.M., Meadows S., Greenfield A., Yang Y., Jain P., Kirigin F.K., Birchmeier C., Wagner E.F., Murphy K.M., Myers R.M., Bonneau R., Littman D.R. A validated regulatory network for Th17 cell specification. Cell 2012, 151:289-303.
115. Li P., Spolski R., Liao W., Wang L., Murphy T.L., Murphy K.M., Leonard W.J. BATF-JUN is critical for IRF4-mediated transcription in T cells. Nature 2012, 490:543-546.
116. Zheng Y., Chaudhry A., Kas A., deRoos P., Kim J.M., Chu T.T., Corcoran L., Treuting P., Klein U., Rudensky A.Y. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 2009, 458:351-356.
117. Staudt V., Bothur E., Klein M., Lingnau K., Reuter S., Grebe N., Gerlitzki B., Hoffmann M., Ulges A., Taube C., Dehzad N., Becker M., Stassen M., Steinborn A., Lohoff M., Schild H., Schmitt E., Bopp T. Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 2010, 33:192-202.
118. Tamiya T., Ichiyama K., Kotani H., Fukaya T., Sekiya T., Shichita T., Honma K., Yui K., Matsuyama T., Nakao T., Fukuyama S., Inoue H., Nomura M., Yoshimura A. Smad2/3 and IRF4 play a cooperative role in IL-9-producing T cell induction. J. Immunol. 2013, 191:2360-2371.
119. Bollig N., Brustle A., Kellner K., Ackermann W., Abass E., Raifer H., Camara B., Brendel C., Giel G., Bothur E., Huber M., Paul C., Elli A., Kroczek R.A., Nurieva R., Dong C., Jacob R., Mak T.W., Lohoff M. Transcription factor IRF4 determines germinal center formation through follicular T-helper cell differentiation. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:8664-8669.
120. Hotamisligil G.S., Erbay E. Nutrient sensing and inflammation in metabolic diseases. Nat. Rev. Immunol. 2008, 8:923-934.
121. Berg A.H., Scherer P.E. Adipose tissue, inflammation, and cardiovascular disease. Circ. Res. 2005, 96:939-949.
122. Hofer M.J., Campbell I.L. Type I interferon in neurological disease-the devil from within. Cytokine Growth Factor Rev. 2013, 24:257-267.
123. Xu W.D., Pan H.F., Ye D.Q., Xu Y. Targeting IRF4 in autoimmune diseases. Autoimmun. Rev. 2012, 11:918-924.
124. Rogatsky I., Chandrasekaran U., Manni M., Yi W., Pernis A.B. Epigenetics and the IRFs: A complex interplay in the control of immunity and autoimmunity. Autoimmunity 2013, 10.3109/08916934.2013.853050.
125. Eguchi J., Kong X., Tenta M., Wang X., Kang S., Rosen E.D. Interferon regulatory factor 4 regulates obesity-induced inflammation through regulation of adipose tissue macrophage polarization. Diabetes 2013, 62:3394-3403.
126. Pourcet B., Feig J.E., Vengrenyuk Y., Hobbs A.J., Kepka-Lenhart D., Garabedian M.J., Morris S.M., Fisher E.A., Pineda-Torra I. LXRalpha regulates macrophage arginase 1 through PU.1 and interferon regulatory factor 8. Circ. Res. 2011, 109:492-501.
127. Leonard D., Svenungsson E., Sandling J.K., Berggren O., Jonsen A., Bengtsson C., Wang C., Jensen-Urstad K., Granstam S.O., Bengtsson A.A., Gustafsson J.T., Gunnarsson I., Rantapaa-Dahlqvist S., Nordmark G., Eloranta M.L., Syvanen A.C., Ronnblom L. Coronary heart disease in systemic lupus erythematosus is associated with interferon regulatory factor-8 gene variants. Circ. Cardiovasc. Genet. 2013, 6:255-263.
128. Sun H., Wang Y. Interferon Regulatory Factors in Heart: Stress Response Beyond Inflammation. Hypertension 2014, 63:663-664.
129. Hauser S.L., Oksenberg J.R. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron 2006, 52:61-76.
130. Horiuchi M., Wakayama K., Itoh A., Kawai K., Pleasure D., Ozato K., Itoh T. Interferon regulatory factor 8/interferon consensus sequence binding protein is a critical transcription factor for the physiological phenotype of microglia. J. Neuroinflammation 2012, 9:227.
131. Minten C., Terry R., Deffrasnes C., King N.J., Campbell I.L. IFN regulatory factor 8 is a key constitutive determinant of the morphological and molecular properties of microglia in the CNS. PLoS ONE 2012, 7:e49851.
132. Masuda T., Tsuda M., Yoshinaga R., Tozaki-Saitoh H., Ozato K., Tamura T., Inoue K. IRF8 is a critical transcription factor for transforming microglia into a reactive phenotype. Cell Rep. 2012, 1:334-340.
133. Yoneyama M., Suhara W., Fukuhara Y., Fukuda M., Nishida E., Fujita T. Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J. 1998, 17:1087-1095.
134. van der Horst A., Burgering B.M. Stressing the role of FoxO proteins in lifespan and disease. Nat. Rev. Mol. Cell Biol. 2007, 8:440-450.
135. Fitzgerald K.A., McWhirter S.M., Faia K.L., Rowe D.C., Latz E., Golenbock D.T., Coyle A.J., Liao S.M., Maniatis T. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 2003, 4:491-496.
136. Landre V., Pion E., Narayan V., Xirodimas D.P., Ball K.L. DNA-binding regulates site-specific ubiquitination of IRF-1. Biochem. J. 2013, 449:707-717.
137. Yang H., Lee S.M., Gao B., Zhang J., Fang D. Histone deacetylase sirtuin 1 deacetylates IRF1 protein and programs dendritic cells to control Th17 protein differentiation during autoimmune inflammation. J. Biol. Chem. 2013, 288:37256-37266.
138. Praetorius C., Grill C., Stacey S.N., Metcalf A.M., Gorkin D.U., Robinson K.C., Van Otterloo E., Kim R.S., Bergsteinsdottir K., Ogmundsdottir M.H., Magnusdottir E., Mishra P.J., Davis S.R., Guo T., Zaidi M.R., Helgason A.S., Sigurdsson M.I., Meltzer P.S., Merlino G., Petit V., Larue L., Loftus S.K., Adams D.R., Sobhiafshar U., Emre N.C., Pavan W.J., Cornell R., Smith A.G., McCallion A.S., Fisher D.E., Stefansson K., Sturm R.A., Steingrimsson E. A Polymorphism in IRF4 Affects Human Pigmentation through a Tyrosinase-Dependent MITF/TFAP2A Pathway. Cell 2013, 155:1022-1033.